No Safe or Effective Antitussive Medications for Children Under 2 Years
There are no approved or recommended over-the-counter (OTC) cough suppressant medications for children younger than 2 years of age. The FDA has issued warnings against using these medications in young children, and manufacturers have voluntarily relabeled OTC cough and cold products to state "do not use in children under 4 years of age" 1.
Why These Medications Are Not Available
The 2020 CHEST guidelines explicitly state that OTC cough medications have little, if any, benefit in symptomatic control of cough in children, and preparations containing antihistamines and dextromethorphan are associated with adverse events, including reported deaths from toxicity in young children 1. This represents a critical safety concern that outweighs any theoretical benefit.
Key Safety Issues:
- Documented fatalities: Between 1969-2006, there were 54 deaths associated with decongestants and 69 deaths associated with antihistamines in children ≤6 years, with the majority occurring in children under 2 years 2
- Common causes: Drug overdose from using multiple products, medication errors, and accidental exposures
- Lack of efficacy data: No well-designed contemporary research supports the efficacy of codeine, hydrocodone, dextromethorphan, diphenhydramine, or guaifenesin for URI-associated pediatric cough 3
What IS Available and Recommended
For Children ≥12 Months: Honey
Honey is the only evidence-based treatment option for cough in children over 1 year of age 1. The CHEST guidelines state that honey may offer more relief for cough symptoms than no treatment, diphenhydramine, or placebo 1.
Critical caveat: Never give honey to infants under 12 months due to botulism risk.
Prescription Opioids: Also Not Recommended
In 2018, the FDA restricted prescription opioid cough and cold medicines to adults ≥18 years only 1. The CHEST guidelines explicitly recommend avoiding codeine-containing medications in children with acute cough because of potential for serious side effects including respiratory distress 1.
The Underlying Principle
Cough in children should be treated based on etiology, not symptomatically 1. The guidelines emphasize that there is no evidence for using medications for symptomatic relief of cough alone. Instead:
- If cough is due to asthma: Treat with appropriate asthma medications (inhaled corticosteroids for children ≥1 year with budesonide nebulizer solution) 4
- If cough is due to bacterial infection: Treat with antibiotics
- If cough is due to viral URI: Supportive care only (no antitussives)
Common Pitfall to Avoid
Do not prescribe or recommend OTC cough medications simply because parents are requesting treatment. The evidence shows these medications provide no benefit and carry real mortality risk in this age group. Education about the protective role of cough and reassurance about the self-limited nature of most viral illnesses is the appropriate management 1, 5.
Bottom Line for Clinical Practice
For a child under 2 years with dry cough:
- Identify the underlying cause (viral URI, asthma, bacterial infection, other)
- Treat the underlying condition if indicated
- For viral URI: Supportive care only—no antitussive medications
- For children ≥12 months: Honey can be offered (dose: 2.5-5 mL as needed)
- Never use: OTC cough/cold medications, codeine, dextromethorphan, antihistamines, or decongestants
The market has appropriately removed these products for children under 2-4 years because they don't work and can cause death 6, 7.